EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis

Davide Bertolla, Andrea Conti

Dermatology Reports · 30.01.2026 · 18 (4)

DOI: 10.4081/dr.2026.10240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Reports, online erschienen am 30.01.2026. Verfasst von Davide Bertolla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the case of a 50-year-old woman with severe palmoplantar psoriasis who developed alopecia areata (AA) 2 months after initiating treatment with tildrakizumab (100 mg subcutaneously). The patient had no personal or familial history of autoimmune disorders, and the diagnosis of AA was confirmed by clinical and trichoscopic evaluation. Tildrakizumab was discontinued, and the patient was treated with topical corticosteroids and low-dose oral methylprednisolone, achieving complete hair regrowth within 6 months. Psoriasis subsequently recurred, and treatment was successfully switched to bimekizumab, with sustained remission and no adverse events. To the best of our knowledge, published reports of new-onset AA during tildrakizumab therapy for psoriasis are lacking. The temporal correlation, lack of confounding risk factors, and resolution upon drug withdrawal suggest a causal relationship. This case expands the spectrum of paradoxical reactions (PRs) to biologic therapies and highlights the need for vigilance regarding autoimmune manifestations during interleukin (IL)-23 inhibition.

Schlagwörter

Stichwörter der Autor:innen

Alopecia areatabiological drugspalmoplantar psoriasistildrakizumab

Autor:innen und Institutionen

  • Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara.
  • Dermatologic Unit, Department of Surgery, Infermi Hospital, AUSL Romagna, Rimini.

Zitieren

APA

Bertolla, D., & Conti, A. (2026). Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis. Dermatology Reports, 18(4). https://doi.org/10.4081/dr.2026.10240

Vancouver

Bertolla D, Conti A. Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis. Dermatology Reports. 2026;18(4). doi:10.4081/dr.2026.10240

BibTeX
@article{Bertolla2026,
  author = {Bertolla, Davide and Conti, Andrea},
  title = {Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis},
  journal = {Dermatology Reports},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.4081/dr.2026.10240}
}
Kostenlos starten →